COMMUNIQUÉS West-GlobeNewswire
-
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
12/08/2024 - 22:01 -
Erasca Reports Second Quarter 2024 Business Updates and Financial Results
12/08/2024 - 22:01 -
Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update
12/08/2024 - 22:01 -
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
12/08/2024 - 22:01 -
Invivyd to Host Conference Call Discussing Second Quarter 2024 Financial Results and Business Highlights
12/08/2024 - 22:01 -
Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024
12/08/2024 - 22:01 -
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21
12/08/2024 - 22:00 -
Eric Samples Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
12/08/2024 - 19:52 -
NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14
12/08/2024 - 17:30 -
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
12/08/2024 - 17:00 -
Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results
12/08/2024 - 17:00 -
scPharmaceuticals Announces Pricing of $50.0 Million Public Offering
12/08/2024 - 15:48 -
Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for Toripalimab as First-Line Treatment of Unresectable/Metastatic Melanoma
12/08/2024 - 15:30 -
NEXGEL to Report Second Quarter 2024 Financial Results on August 14th
12/08/2024 - 15:15 -
60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study
12/08/2024 - 15:12 -
Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
12/08/2024 - 15:05 -
Health AI Company Akido Establishes Ethics Council on Artificial Intelligence in Healthcare with Caltech’s Merkin Institute and the Keck School of Medicine of USC Department of Surgery
12/08/2024 - 15:05 -
MAPS Statement on FDA Complete Response Letter for MDMA-Assisted Therapy for PTSD New Drug Application
10/08/2024 - 03:33 -
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
10/08/2024 - 00:18
Pages